AAD
Patient Care Online provides primary care physicians with essential insights from the 2025 American Academy of Dermatology (AAD) Annual Meeting. Access expert guidance, clinical updates, and actionable content on the latest advancements in dermatologic care—all tailored to enhance your practice and patient outcomes.
Conference Highlights
Expert Interviews
Featured
Breakthroughs in Atopic Dermatitis with Linda Stein Gold, MD
Linda Stein Gold, MD
Sydney Jennings
March 9 2025
Daniel Butler, MD: Pearls for Primary Care When Treating and Referring Older Adults for Chronic Itch
Daniel Butler, MD
Grace Halsey
March 9 2025
Rocatinlimab, an OX40 Inhibitor, Achieves Positive Results in Atopic Dermatitis Treatment: ROCKET-Horizon Topline Findings
Grace Halsey
March 9 2025
Atopic Dermatitis Breakthrough: Linda Stein Gold, MD, on Tapinarof's Treatment-Free Benefits
Sydney Jennings
March 9 2025
Benjmain Ungar, MD: Addressing the Immunological Causes of Seborrheic Dermatitis
Benjamin Ungar, MD
Sydney Jennings
March 9 2025
Dupilumab Demonstrates Superior Long-Term Persistence Over Upadacitinib and Tralokinumab in Atopic Dermatitis
Grace Halsey
March 9 2025
Atopic Dermatitis: Investigational Anti-OX40L Antibody Shows Sustained Itch Relief, Even After Discontinuation
Sydney Jennings
March 8 2025
Atopic Dermatitis: It’s Not the Food, I Promise You
Peter A Lio, MD
Grace Halsey
March 8 2025
Ruxolitinib Cream 1.5% Demonstrates Efficacy in Prurigo Nodularis: Phase 3 Findings
Patient Care Editorial Staff
March 8 2025
Rocatinlimab Shows Significant Efficacy in Moderate to Severe Atopic Dermatitis: Phase 3 IGNITE Trial Results
Grace Halsey
March 8 2025
Icotrokinra Shows Promise for Moderate-to-Severe Plaque Psoriasis in Phase 3 Trials
Patient Care Editorial Staff
March 8 2025
Tapinarof Cream 1% Demonstrates Sustained Disease Control in Adults, Children with Atopic Dermatitis
Sydney Jennings
March 8 2025
Lebrikizumab Improves Patient-Reported Outcomes in Atopic Dermatitis for Patients Previously Treated with Dupilumab
Grace Halsey
March 8 2025
Ruxolitinib Cream Demonstrates Long-Term Disease Control in Atopic Dermatitis
Grace Halsey
March 7 2025
Real-World Evidence Reveals Key Insights on Hidradenitis Suppurativa
Patient Care Editorial Staff
March 7 2025
Bimekizumab Demonstrates Sustained Efficacy in Moderate-to-Severe Plaque Psoriasis Over Five Years
Sydney Jennings
March 7 2025
Roflumilast Foam 0.3% Significantly Reduces Pruritus and Improves Quality of Life in Scalp and Body Psoriasis
Grace Halsey
March 7 2025
Roflumilast Cream 0.15% Well Tolerated in Atopic Dermatitis Patients with Prior Treatment Failures
Grace Halsey
March 7 2025
Tildrakizumab Shows Efficacy for Nail Psoriasis in Phase 3b Trial
Patient Care Editorial Staff
March 7 2025
AAD 2025: Clear Skin in Half of Patients Who Received Monthly Maintenance Injection of Ebglyss for AD
Patient Care Editorial Staff
March 7 2025
AAD 2025: Atopic Dermatitis Preview
Patient Care Editorial Staff
March 7 2025
What to Know Before AAD 2025: Product Snapshots of Nonsteroidal Topical Treatments for Eczema
Mona Shahriari, MD
Grace Halsey
March 4 2025
Atopic Dermatitis Primer for AAD 2025: Dermatologist Mona Shahriari, MD, Explains the Rise in Prevalence
Mona Shahriari, MD
Grace Halsey
March 3 2025
American Academy of Dermatology 2025 Prep: A Dermatologist Considers When Atopic Dermatitis Referral from Primary Care is Indicated
Mona Shahriari, MD
Grace Halsey
February 28 2025
Focus on AAD 2025: Dermatologist Mona Shahriari, MD, Highlights the PCP Role in Atopic Dermatitis Care
Mona Shahriari, MD
Grace Halsey
February 27 2025
Expert Perspectives 2024: Nonsteroidal Topicals for Atopic Dermatitis with Mona Shahriari, MD
Mona Shahriari, MD
Grace Halsey
December 12 2024
Nonsteroidal Topical Treatments for Eczema: A Product Snapshot with Mona Shahriari, MD
Mona Shahriari, MD
Grace Halsey
November 6 2024
Why is Atopic Dermatitis Prevalence Rising? Dermatologist Mona Shahriari, MD, Parses the Trends
Mona Shahriari, MD
Grace Halsey
October 22 2024
